KMID : 0369820090390030177
|
|
Jorunal of Korean Pharmaceutical Sciences 2009 Volume.39 No. 3 p.177 ~ p.183
|
|
HPLC Analysis of Piroxicam in the Rabbit Plasma and its Bioavailability after the Transdermal Administration of Patches
|
|
Jung Yeun-Bok
Shin Dae-Hwan Lee Gyeong-Bok Lee Chong-Kil Park Seung-Hyeok
|
|
Abstract
|
|
|
A rapid and sensitive reversed-phase high performance liquid hromatography (HPLC) method was developed for the determination of piroxicam in the rabbit plasma. After a treatment of plasma sample by liquid-liquid extraction,the drug was analyzed on an HPLC system with ultraviolet detection at 330 nm. HPLC was carried out using reversed-phase isocratic elution with a C18 column, a mobile phase of a mixture of acetonitril, doubly deionized water, and acetic acid (43.74:56.00:0.26 v/v%) at a flow rate of 1.1 mL/min. The chromatograms showed good resolution and sensitivity and no interference of plasma. The calibration curve for the drug in plasma sample was linear over the concentration range of 0.01-2.0 ¥ìg/mL. The intra- and inter-day assay accuracies of this method ranged from 86.82% to 108.33% of normal values and the precision did not exceed 13% of relative standard deviation. The plasma concentration of piroxicam decreased to below the quantifiable limit at 12 hr after the i.v. bolus administration to rabbits following dose of 0.375 mg/kg yielding a apparen t plasma half life of 1.38 hr. The transdermal route prolongs plasma levels of piroxicam. The bioavailability, calculated from the dose-adjusted ratio of the AUCtransdermal to the AUCi.v., was 7.44%. The plasma concentration of piroxicam was detected by 48 hr after the transdermal administration of patch at a dose of 32 mg/kg. This method was suitable for cutaneous absorption studies of piroxicam in the rabbit after transdermal administration of different types of dosages of the drug.
|
|
KEYWORD
|
|
Piroxicam, HPLC, Patch, Cutaneous absorption
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|